Sareum’s small molecule drug discovery expertise builds value by developing drug candidates, focused on cancer and autoimmune disease, for licencing to pharmaceutical and biotechnology companies.
Find out more about us
17 December 2019
20 November 2019
05 November 2019
Find out more
Sareum actively seeks collaboration partners for its research programmes.
Sareum has an innovative pipeline of drug development candidates.
FY Results, October 2019 (Slides)BioTrinity, April 2019 (Slides)
Share price dataRegulatory News Service (RNS)
Sareum LimitedUnit 2A, Langford ArchLondon Road, PampisfordCambridge CB22 3FXUnited Kingdom
tel: +44 (0) 1223 497700fax: +44 (0) 1223 497701
Final Results 2019 Brochure Sept 2019
Annual Report 2019 Notice of AGM 2019